Duvelisib: Phase II data

Top-line data from the open-label, international Phase II DYNAMO trial in 129 patients with follicular lymphoma (n=83), small lymphocytic lymphoma (SLL) (n=28) or marginal zone lymphoma (n=18) who are

Read the full 299 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE